Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Childrens National Medical Center
mi
from
Washington,
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Columbia University Medical Center
mi
from
New York, NY
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Midwest Children's Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Oregon Health and Science University
mi
from
Portland, OR
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Riley Hospital for Children
mi
from
Indianapolis, IN
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Saint Jude Childrens Research Hospital
mi
from
Memphis, TN
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Saint Jude Childrens Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Seattle Children's Hospital
mi
from
Seattle, WA
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
University of Minnesota Cancer Center-Fairview
mi
from
Minneapolis, MN
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
University of Minnesota Cancer Center-Fairview
mi
from
Minneapolis, MN
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
University of California San Francisco Medical Center-Parnassus
mi
from
San Francisco, CA
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
University of California San Francisco Medical Center-Parnassus
mi
from
San Francisco, CA
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated:  1/7/2016
Washington University School of Medicine
mi
from
St. Louis, MO
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Study of the TEM-1 Antibody, MORAb-004 (IND# 103821), in Children With Recurrent or Refractory Solid Tumors
Status: Enrolling
Updated: 1/7/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital Colorado
mi
from
Aurora, CO
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Emory University/Childrens Healthcare of Atlanta
mi
from
Atlanta, GA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Emory University/Childrens Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Riley Children's Hospital
mi
from
Indianapolis, IN
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Johns Hopkins University
mi
from
Baltimore, MD
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Harvard University, Boston Children's Hospital
mi
from
Boston, MA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Harvard University, Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of Michigan
mi
from
Ann Arbor, MI
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Columbia-Presbyterian
mi
from
New York, NY
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Columbia-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of Cincinnati, Cincinnati Children's Hospital
mi
from
Cincinnati, OH
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of Cincinnati, Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Children's Medical Center of Dallas
mi
from
Dallas, TX
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Children's Medical Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Baylor College of Medicine
mi
from
Houston, TX
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Univ of Washington
mi
from
Seattle, WA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
University of California at San Francisco
mi
from
San Francisco, CA
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Mount Sinai Hosp
mi
from
New York, NY
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated:  1/11/2016
Hospital for Sick Children
mi
from
Toronto,
A Multi-Center Group to Study Acute Liver Failure in Children
A Multi-Center Group to Study Acute Liver Failure in Children
Status: Enrolling
Updated: 1/11/2016
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Prevention of Surgical Site Infection After Cesarean Delivery
Chlorhexidine-Alcohol Vs. Povidone-Iodine for Prevention of Surgical Site Infection After Cesarean Delivery: A Randomized Trial
Status: Enrolling
Updated:  1/11/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Prevention of Surgical Site Infection After Cesarean Delivery
Chlorhexidine-Alcohol Vs. Povidone-Iodine for Prevention of Surgical Site Infection After Cesarean Delivery: A Randomized Trial
Status: Enrolling
Updated: 1/11/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement
Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement - Observational Arm
Status: Enrolling
Updated:  1/12/2016
UPMC Comprehensive Lung Center
mi
from
Pittsburgh, PA
Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement
Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement - Observational Arm
Status: Enrolling
Updated: 1/12/2016
UPMC Comprehensive Lung Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Evaluation of Directed Antimicrobial Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy (TRUSP)
Status: Enrolling
Updated:  1/12/2016
Northwestern University Department of Urology
mi
from
Chicago, IL
Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Evaluation of Directed Antimicrobial Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy (TRUSP)
Status: Enrolling
Updated: 1/12/2016
Northwestern University Department of Urology
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
A Phase 2, Randomized, Single-blind, Controlled, Single-Center Study to Compare the Safety and Immunogenicity of One Dose of Chiron Meningococcal ACWY Conjugate Vaccine With One Dose of Licensed Meningococcal ACWY Polysaccharide Vaccine Administered to Healthy Children 2-10 Years of Age and an Open-label Study to Assess the Safety and Immunogenicity of One Dose of Chiron Meningococcal ACWY Conjugate Vaccine Administered to Healthy Toddlers 12-23 Months of Age
Status: Enrolling
Updated:  1/12/2016
Kaiser Permanente Vaccine Study Center
mi
from
Oakland, CA
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
A Phase 2, Randomized, Single-blind, Controlled, Single-Center Study to Compare the Safety and Immunogenicity of One Dose of Chiron Meningococcal ACWY Conjugate Vaccine With One Dose of Licensed Meningococcal ACWY Polysaccharide Vaccine Administered to Healthy Children 2-10 Years of Age and an Open-label Study to Assess the Safety and Immunogenicity of One Dose of Chiron Meningococcal ACWY Conjugate Vaccine Administered to Healthy Toddlers 12-23 Months of Age
Status: Enrolling
Updated: 1/12/2016
Kaiser Permanente Vaccine Study Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Usc La Nichd Crs
mi
from
Alhambra, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Usc La Nichd Crs
mi
from
Alhambra, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Miller Children's Hosp. Long Beach CA NICHD CRS
mi
from
Long Beach, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Miller Children's Hosp. Long Beach CA NICHD CRS
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's Hospital of Los Angeles NICHD CRS
mi
from
Los Angeles, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's Hospital of Los Angeles NICHD CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
mi
from
Los Angeles, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
University of California, UC San Diego CRS
mi
from
San Diego, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
University of California, UC San Diego CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of California San Francisco NICHD CRS
mi
from
San Francisco, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of California San Francisco NICHD CRS
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Harbor UCLA Medical Center NICHD CRS
mi
from
Torrance, CA
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Harbor UCLA Medical Center NICHD CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Children's National Med. Ctr. Washington DC NICHD CRS
mi
from
Washington,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Children's National Med. Ctr. Washington DC NICHD CRS
mi
from
Washington,
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Howard Univ. Washington DC NICHD CRS
mi
from
Washington,
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Howard Univ. Washington DC NICHD CRS
mi
from
Washington,
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
South Florida CDTC Ft Lauderdale NICHD CRS
mi
from
Fort Lauderdale, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
South Florida CDTC Ft Lauderdale NICHD CRS
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Univ. of Florida Jacksonville NICHD CRS
mi
from
Jacksonville, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Univ. of Florida Jacksonville NICHD CRS
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
Pediatric Perinatal HIV Clinical Trials Unit CRS
mi
from
Miami, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
Pediatric Perinatal HIV Clinical Trials Unit CRS
mi
from
Miami, FL
Click here to add this to my saved trials
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated:  1/12/2016
USF - Tampa NICHD CRS
mi
from
Tampa, FL
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth
Status: Enrolling
Updated: 1/12/2016
USF - Tampa NICHD CRS
mi
from
Tampa, FL
Click here to add this to my saved trials